New 'Triple G' Retatrutide ('Reta') Weight Loss Drug Shows 'Insane' Results It protects heart health The American Heart Association and American Stroke Association now recommend that healthcare professionals consider GLP-1 drugs to reduce stroke risk for certain patients
While certainly justified at the time by the data then available, the results and enthusiasm following use of these agents have, if anything, grown since then
Victoza/Saxenda (liraglutide) These daily injectable GLP-1 medications fall in the middle: After first use, they can be kept at room temperature for up to 30 days
26,32 Additionally, treatments are often associated with side effects and/or exhibit insufficient efficacy
Patients should be counselled about dietary modifications, such as reducing fat intake and eating smaller, more frequent meals, which can help manage these symptoms
In a 2023 randomized trial published in the ClinicalTrials.gov database, participants experienced an average of 1724% total body weight reduction after 48 weeks of treatment